发明名称 |
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
摘要 |
Ophthalmically therapeutic materials, such as liquid-containing compositions and polymeric drug delivery systems, include a therapeutic component that includes an Glucocorticoid Derivative which, upon delivery to the posterior segment of a mammalian eye, does not significantly diffuse to the anterior segment of said eye. Methods of making and using the present materials are also described. |
申请公布号 |
US9259429(B2) |
申请公布日期 |
2016.02.16 |
申请号 |
US201414463034 |
申请日期 |
2014.08.19 |
申请人 |
Allergan, Inc. |
发明人 |
Edelman Jeffrey L.;Harrison Kelly M. |
分类号 |
A61K31/74;A61K31/573;A61K9/00;A61K31/56;A61K9/16;A61K31/728;A61K47/36 |
主分类号 |
A61K31/74 |
代理机构 |
|
代理人 |
Phan Brigitte C. |
主权项 |
1. A method of treating macular edema of a mammalian eye comprising periocular administration of a composition comprising a therapeutically effective amount of hyaluronic acid and a glucocorticoid derivative comprising an acyl group linked to C17 via an ester linkage. |
地址 |
Irvine CA US |